Investor Alert

New York Markets Close in:

June 10, 2020, 3:52 a.m. EDT

Radiopharmaceuticals Market (Pre & Post COVID-19 Market Estimates) 2020- Industry Size, Share, Growth, Company Profiles, Competitive Landscape And Key Regions

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jun 10, 2020 (MarketersMedia via COMTEX) -- Global Medical Implants Research Report: Information by Type (Orthopedic Implants, Cardiac Implants, Spinal Implants, Dental Implants, Ophthalmic Implants, Cosmetic Implants), Type of Material (Metallic Material, Ceramic Material, Polymers Material), End User (Hospitals & Clinics, Research Laboratories) and Region - Forecast till 2023

pune, India - June 10, 2020 /MarketersMedia/ --

Global Market for Radiopharmaceuticals-Overview

The global radiopharmaceuticals market is gaining speeds and recognition with the growing applications. Development of new methods for oncological, cardiological and neurological therapies with the help of radiopharmaceuticals in attracting the audience from all around the world. The global radiopharmaceuticals market is expected to touch nearly 08 % annual growth marker during the survey period.

Download Sample Table of Content PDF of COVID-19/CoronaVirus Impact Analysis of Radiopharmaceuticals Market 2020@ https://www.marketresearchfuture.com/sample_request/1650

With the demands for better healthcare products and the increasing number of untreatable diseases, the application of radioisotopes with biological molecules has opened new ways of treatment and has introduced a ray of hope among the doctors and patients. Government agencies are investing largely in the research & development programs in this field to search for new opportunities and with fewer side effects. Earlier treatment of chronic diseases and timely treatment is the key to the best results. Radiopharmaceuticals have found a significant usage in the treatment of ailments like cancer and tumours.

This success has compelled the authorities to make substantial investments in this field and look for other possibilities, which has helped the market in gaining a robust place in future aspects. The emphasis is on searching for better therapies with minimum side effects and maximum benefits. Planned production, transportation and storage are the factors to keep in mind when dealing with nuclear elements. This market is not very widespread and has limited market players due to the presence of rigid regulations for existing companies and new players.

Markett Segments of Radiopharmaceuticals

The global radiopharmaceuticals market is segmented into two parts, which are:

Types of Radiopharmaceuticals: The of radiopharmaceuticals are used in two types, namely diagnostics and therapeutics.

Applications: Radiopharmaceuticals have successfully been used against oncological, cardiological, neurological and other severe conditions.

Regional Overview of Radiopharmaceuticals

The global radiopharmaceuticals market is observed in America, Asia Pacific, Europe and the Middle East & African regions.

The American region is the largest market in the present. It will hold the same position during the survey period due to the rise in chronic disease cases, presence of well-established healthcare system and key market players. Europe is the second-largest market due to demand for better medicine & treatments, large investments in research & development and increasing chronic diseases events.

The Asia Pacific region is the third-largest market and will show considerable growth throughout the survey period. The increasing chronic disease counts, large population cover and improving healthcare structures are boosting the market here. The rest of the regions will grow at slowest rates due to struggling overall conditions.

Top Key Players of Radiopharmaceuticals

The prominent players in the global radiopharmaceuticals market are GE Healthcare, Lantheus Medical Imaging, Inc., Novartis AG, BWX Technologies, Inc., Siemens Healthineers, IRE ELiT, JSC Isotope, NTP Radioisotopes SOC Ltd, Curium, Australian Nuclear Science and Technology Organization (ANSTO), and others.

Recent Industry News

1 2
This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »
Link to MarketWatch's Slice.